在糖尿病预防计划结果研究中,与微血管并发症相关的共享和独特的代谢学概况
Wei Perng1, Shiyu Shu2, David M Nathan3
1Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, Department of Epidemiology at the Colorado School of Public Health and the University of Colorado Anschutz Medical Campus, Aurora, CO, USA. dppmail@bsc.gwu.edu.
Diabetologia
|October 11, 2025
概括
不同的代谢物概况与糖尿病并发症有关,如病,视网膜病和神经病. 识别这些代谢特征可以提高对疾病特异性途径和糖尿病共享机制的理解.
科学领域:
- 代谢学 代谢学 代谢学
- 糖尿病并发症 糖尿病并发症
- 纵向研究 纵向研究
背景情况:
- 糖尿病微血管并发症 (脏病,视网膜病,神经病) 显著影响患者的健康.
- 了解这些并发症的代谢基础对于开发有针对性的干预措施至关重要.
研究的目的:
- 识别与病,视网膜病和神经病相关的共享和独特的代谢物概况.
- 在糖尿病预防计划结果研究 (DPPOS) 中,在15年的随访期内分析这些关联.
主要方法:
- 启动LASSO回归被用于确定353个注释代谢物和微血管并发症之间的关联.
- 测试了与糖尿病预防计划 (DPP) 治疗臂的相互作用.
- 多变量模型用于聚合和治疗特定分析.
主要成果:
- 在105种已识别的代谢物中,74种与单一并发症有关,27种与两种并发症有关,四种与所有三种并发症有关.
- 希斯蒂丁和氨酸与较低的脏病发病率有关.
- N-卡巴莫伊尔-β-氨酸和C22:0-sphingomyelin分别显示了与脏病和神经病的治疗特异性关联.
- 奎诺林酸与生活方式干预组中神经病变的几率增加有关.
结论:
- 不同的代谢物概况与个别的微血管并发症有关.
- 这些发现强调了需要表征糖尿病的共同和并发症特异性病理生理机制的需要.
相关概念视频
Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Complications of Diabetes Mellitus
35
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
35
Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59


